JOSÉ ANTONIO
EGIDO RODRÍGUEZ
Researcher in the period 1983-2020
Duke Clinical Research Institute
Durham, Estados UnidosPublications in collaboration with researchers from Duke Clinical Research Institute (10)
2019
-
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry
JAMA Cardiology, Vol. 4, Núm. 6, pp. 526-548
-
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
American Heart Journal, Vol. 213, pp. 35-46
-
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry
Clinical Cardiology, Vol. 42, Núm. 5, pp. 553-560
2018
-
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry
European Heart Journal, Vol. 39, Núm. 6, pp. 464-473
-
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
PLoS ONE, Vol. 13, Núm. 1
-
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835
2017
2016
-
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists
British Journal of Haematology, Vol. 174, Núm. 4, pp. 610-623
-
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry
PLoS ONE, Vol. 11, Núm. 10
2015
-
Ezetimibe added to statin therapy after acute coronary syndromes
New England Journal of Medicine, Vol. 372, Núm. 25, pp. 2387-2397